SUPRECUR

This brand name is authorized in Austria, Estonia, Japan, Malta, UK.

Active ingredients

The drug SUPRECUR contains one active pharmaceutical ingredient (API):

1	Buserelin UNII 13U86G7YSP - BUSERELIN ACETATE
	Buserelin is a synthetic peptide. It is a superactive analogue of natural gonadotrophin releasing hormone (gonadorelin, LHRH or GNRH). After an initial stimulation of gonadotrophin release, it down-regulates the hypothalanic-pituitary-gonadal axis.
	Read more about Buserelin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SUPRECUR Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
SUPRECUR Nasal spray solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02AE01	Buserelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1040443
GB	Medicines & Healthcare Products Regulatory Agency	39296, 42566
JP	医薬品医療機器総合機構	2499701R1052
MT	Medicines Authority	AA770/06102